Novo Integrated Sciences Inc (NVOS)

[xtyleradx]

Took some. Why not

[Sibware]

error

[Sibware]

error

[Sibware]

Textbook S-filing b4 any-news cuz Streeterville and other-friends (GPE Global agreement recently amended for an extension of 1 more year till June 18 2025) always buy b4 any note or other amendment to get the maximum gain$

[Dr PennyStock]

Good to know. Thanks. Technically I think it may shoot up at any moment, due to the very low volume, higher lows on both charts, daily and weekly, and some indicators showing strong support.

[Sibware]

NVOS:S-1 or S-3,due-tmrw b4 any-news from last-8K

[Dr PennyStock]

It's taking a little more time, but, the run to $5 - $5.38 will happen. I see lots of accumulation in the 7s.

[SolarRevolution]

Bring on the news! Could we see HSBC monetization pre-market!!!!!

[SolarRevolution]

I’m following the companies news releases, HSBC confirmed Swift MT 760 June 13th, there were six news releases from May 31 to June 13,

When I say the market expects news the share price recovery proves there is buying in anticipation.

When you make the call for $5 plus are you speculating ?

[Sibware]

NVOS:30' full reset almost done!!!

[Dr PennyStock]

Are you speculating, or news are really expected today?

[Sibware]

NVOS:Rainbow-formation-completed with sma-50 over sma-100 now.0.79 first support on 15' held very well till now on decent Volume early today

[Sibware]

Yup they always short b4 next pop, but intentional and good to chill Daily chart. Notes mechanics 101 by insiders!!!
Added on that nice PM dip and 15' reset

[SolarRevolution]

That is the expectation! Market looking for some great news today

[Dr PennyStock]

The run to $5 - $5.38 will start soon. Then, after a pullback, $10 - $15 is the target.

Weekly chart: https://schrts.co/WwcsEcmE

[SolarRevolution]

Exciting week coming up for NVOS and shareholders!

[rouge Vaughn]

yeah 350k shares covered along with 64 percent short for the day, of all the shares traded if that goes up we should see a run up or news soon still looking for 1.59 and up

[SolarRevolution]

Nice support back up above $0.80 market anticipates a positive update on HSBC early this week.

$$$

:D

[Dr PennyStock]

I am expecting a reversal candle today, because the pullback to this level was to retrace 50% of the top of the run at 1.40.

Up from here, IMO

[Sibware]

Shorts covering today just like recent Friday.First day with buys almost equal to sells ensued

[Sibware]

Fast Sto curling back up on Daily.Loved that huge selloff PM.Reloaded

[Sibware]

Time to break daily psar at 0.64 today.Twas fun to trade it on all fluff news lately.Not sure when we see next pop

[rouge Vaughn]

when shorts start to pop out and post it tells me alot is yet to come

[rouge Vaughn]

dude get a lie why are you she it was quite before you showed up nobody gives 2fs about your opinion

[SolarRevolution]

Optimistic company will be closing the $78,000,000 and Ophir gems acquisition within days

[portfoliomaster]

IDIOT

[portfoliomaster]

SCAM

[portfoliomaster]

lol this loser can't stop losing weeeeeeeeeeeeeeeeeeee

you ever see this clown on your board, you know you've invested in a loser SCAM....just go check out all the other boards he's posted on - ALL SCAMS!!!!

[SolarRevolution]

Today 4:30pm would be legendary!

[Sibware]

NVOS:First 075 now.So predictable based on real DD...

[rouge Vaughn]

just waiting on that final pr soo we can touch 1.50 to 5 and up

[Sibware]

Yup.Textbook sma20 test today but i would't mind testing 0.75 and under for a last addition b4 flipping the psar on the hourly near 0.88 atm

Insiders in full control of pps and chart here. Always my preferredd ones

[Dr PennyStock]

The SMA20 is at .80, so that drop to .7731 was just an overreaction. I hope it closes green today, to make a reversal candle.

[SolarRevolution]

Show us the HSBC funds in NVOS account please! Today would be grand!

[Sibware]

Textbook nose-dive 4 and by insiders.Adding under 0.80

[rouge Vaughn]

1.59 and up

[Sibware]

Looking for sma20 test PM tmrw at 0.78 or anything below 0.80 to add more be any bounce...0.784 was hit June 7th pm...
Then we push the Daily top bolly over sma200 later on...

[Dr PennyStock]

The spread is very tightm and this means that this level may be the bottom, so I expect some volume increase with a small spike today or tomorrow.

[Sibware]

NVOS: Adding on my pile again near 0.82 with S1 amendment to close this week

[Sibware]

Fully agree with your Weekly TA. Insiders been flipping on all fluff news lately and no way we gonna bust that top bolly on the weekly. I'm still building a big position of freebies by following 15 and 30' charts by buying bottom and selling top.

Better news coming and S1 amendment closing soon, so they will have lot of shares to push that top bolly up, after accumulating some on recent fake heads

[SolarRevolution]

I’m predicting two news releases every week of June!

1) $78,000,000 in the bank
2) Ophir gemstones collection acquisition completed
3) Share buyback commencement
4) RC note receipt of additional financing

:D

Bring it on NVOS ordo seclorum!

[SolarRevolution]

Market wants to see the $78,000,000 deposited. Next week the market gets what it wants IMO

[Sibware]

NVOS:Psar-flipped on 15' dual H&S pattern

[Sibware]

NVOS:First support 0.91 hit-0.81 next

[Sibware]

NVOS:Hourly and 30' reset in progress,with sma200 at 0.83 on the 30'

[Sibware]

Yup insiders flipped again on fluff news.I did too.Moreover co. added naked short selling investigation early this morning...lol
More fluff again. I'm still trading the chart b4 monetization done

[Dr PennyStock]

Like I said yesterday, they will pull it to .84 before letting it run.
This is what the TA on the weekly chart is pointing to.

[Sibware]

NVOS:Projected $78 million not-today,cuz SBLC monetization not-done yet:

[INV4]

Very nice!

News! Confirmation of the $78M line of credit.

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

06/13/2024 - 04:30 PM

BELLEVUE, Wash.--(BUSINESS WIRE)-- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that it has received confirmation of the issuance of a Standby Letter of Credit (“SBLC”) by HSBC for delivery by Swift MT760, as part of a program designed for monetizing SBLCs. As previously reported, the Company entered into an application for the monetizing program whereby the Company is projected to receive gross funding proceeds of approximately $78 million under the SBLC upon completion of monetization.

The Company expects to use the proceeds to close the acquisition of the Ophir Collection which will result in the sole unfettered ownership of the Ophir Collection by the Company.

"The issuance of the MT760 is the final step prior to monetization. It is exciting to see the progress leading us toward the Ophir Collection acquisition, as well as providing additional funds directed to the previously reported share repurchase program. Our commitment to raising non-dilutive capital for the Company remains foremost in our efforts as we consider uniquely advantageous funding sources,” stated Robert Mattacchione, the Company’s CEO and Board Chairman.

About Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation. Novo offers an essential and differentiated solution to deliver, or intend to deliver, these services and products through the integration of medical technology, advanced therapeutics, and rehabilitative science.

We believe that “decentralizing” healthcare, through the integration of medical technology and interconnectivity, is an essential solution to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and in the future. Specific to non-critical care, ongoing advancements in both medical technology and inter-connectivity are allowing for a shift of the patient/practitioner relationship to the patient’s home and away from on-site visits to primary medical centers with mass-services. This acceleration of “ease-of-access” in the patient/practitioner interaction for non-critical care diagnosis and subsequent treatment minimizes the degradation of non-critical health conditions to critical conditions as well as allowing for more cost-effective healthcare distribution.

The Company’s decentralized healthcare business model is centered on three primary pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers:

First Pillar: Service Networks. Deliver multidisciplinary primary care services through (i) an affiliate network of clinic facilities, (ii) small and micro footprint sized clinic facilities primarily located within the footprint of box-store commercial enterprises, (iii) clinic facilities operated through a franchise relationship with the Company, and (iv) corporate operated clinic facilities.
Second Pillar: Technology. Develop, deploy, and integrate sophisticated interconnected technology, interfacing the patient to the healthcare practitioner thus expanding the reach and availability of the Company’s services, beyond the traditional clinic location, to geographic areas not readily providing advanced, peripheral based healthcare services, including the patient’s home.
Third Pillar: Products. Develop and distribute effective, personalized health and wellness product solutions allowing for the customization of patient preventative care remedies and ultimately a healthier population. The Company’s science-first approach to product innovation further emphasizes our mandate to create and provide over-the-counter preventative and maintenance care solutions.

Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient-first platforms.

For more information concerning Novo Integrated Sciences, please visit www.novointegrated.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," “intend,” "expect," "anticipate," "plan," "potential," "continue," or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in Novo’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown uncertainties and other factors which are, in some cases, beyond Novo’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Novo’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Novo assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240613445709/en/

Chris David, COO
Novo Integrated Sciences, Inc.
[e-mail]
[phone]

Source: Novo Integrated Sciences, Inc.

https://www.stocktitan.net/news/NVOS/novo-integrated-sciences-receives-confirmation-of-issuance-of-sblc-fzo8gvgqspvt.html

$NVOS

[redspeed]

Should I buy or sell?

Let’s ask Borders since he gives financial advice out on social media without any license.

Oh, seems the alleged ex stock touter is preoccupied with nonstop nonsense on his business X account. LMAO